甲状腺多灶性乳头状癌临床病理特征分析及相关因素研究OA
Clinic opathological characteristics of multifocal papillary thyroid carcinoma and factors associated with contralateral occult microcarcinoma
目的 探讨甲状腺多灶性乳头状癌(multifocal papillary thyroid carcinoma,MPTC)的临床病理特征,分析微小MPTC与非微小MPTC的差异,筛选对侧存在隐匿微小癌灶的预测因素,为个体化诊疗提供依据.方法 回顾性分析2021年4月~2024年4月首都医科大学附属北京同仁医院收治的295例MPTC患者临床病理资料.按主癌灶分为微小MPTC组(≤1.0 cm)和非微小MPTC组(>1.0 cm),按对侧腺叶癌灶最大径分为≤0.3 cm组与>0.3 cm组.另有142例超声明确对侧无结节或仅存在≤0.3 cm结节患者,按病理结果分为无癌组与≤0.3 cm癌灶组,进行单因素、多因素Logistic回归及受试者工作特征(ROC)曲线分析.结果 微小MPTC与非微小MPTC在性别、术前促甲状腺激素(TSH)、BRAF V600E突变、Ⅵ区淋巴结转移、癌灶与被膜关系及对侧肿瘤大小差异均有统计学意义(P<0.05).对侧癌灶≤0.3 cm组及>0.3 cm组,仅主癌灶大小存在差异(P<0.05).合并桥本甲状腺炎(HT)、超声发现可疑结节是对侧存在≤0.3 cm隐匿微小癌灶的独立影响因素(P<0.05);HT联合超声征象预测对侧存在≤0.3 cm隐匿微小癌灶的AUC为0.698.结论 微小MPTC与非微小MPTC生物学行为存在显著差异,主癌灶大小与对侧癌灶大小相关.合并HT与超声可疑结节是对侧存在≤0.3 cm隐匿微小癌灶的独立预测因素,联合应用可提高术前评估效能,有助于MPTC手术策略选择.
OBJECTIVE To investigate the clinicopathological features of multifocal papillary thyroid carcinoma(MPTC),analyze differences between micro-MPTC(dominant tumor≤1.0 cm)with non-micro-MPTC(dominant tumor>1.0 cm)screen for independent predictors of contralateral occult microcarcinoma,and guide individualized clinical decision-making.METHODS A retrospective analysis was performed on 295 patients with MPTC who underwent surgery at Beijing Tongren Hospital,Capital Medical University from April 2021 to April 2024.Patients were stratified by the maximum diameter of the dominant tumor into micro-MPTC(≤1.0 cm,n=148)and non-micro-MPTC(>1.0 cm,n=147)groups,and by the maximum diameter of contralateral tumors into≤0.3 cm(n=98)and>0.3 cm(n=153)groups.From this cohort,142 patients with no or only≤0.3 cm contralateral nodules on preoperative ultrasound were further stratified by final pathology into a group with no carcinoma(n=44)and a group with contralateral carcinoma(n=98).Univariate analysis,multivariate logistic regression,and receiver operating characteristic(ROC)curve analysis were performed.RESULTS Significant differences were observed between the micro-and non-micro-MPTC groups in sex,preoperative thyroid-stimulating hormone(TSH)level,BRAF V600E mutation status,central lymph node metastasis(level VI),tumor-capsule relationship,and the size of contralateral tumors(all P<0.05).Between the contralateral≤0.3 cm and>0.3 cm tumor groups,only the size of the dominant tumor was significantly different(P<0.05).Hashimoto's thyroiditis(HT)and ultrasound findings were independent predictive factors for contralateral occult carcinoma≤0.3 cm(both P<0.05).The combination of HT and ultrasound features achieved an area under the ROC curve(AUC)of 0.698 in predicting contralateral occult carcinoma≤0.3 cm.CONCLUSION Micro-MPTC and non-micro-MPTC differ significantly in biological behavior.The size of the dominant lesion is correlated with that of the contralateral carcinoma focus.The coexistence of HT and ultrasonographically suspicious nodules are independent predictors for the presence of a contralateral occult microcarcinoma≤0.3 cm.Their combined use improves the accuracy of preoperative assessment and aids in determining the optimal surgical strategy for MPTC.
朱长雨;陈晓红;李志新;李威;赵京阳;施奕君;张维涛;李新宇
首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 头颈肿瘤与甲状腺外二科,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176首都医科大学附属北京同仁医院 肿瘤中心,北京 100176
甲状腺肿瘤危险因素甲状腺多灶乳头状癌桥本甲状腺炎
Thyroid NeoplasmsRisk Factorsmultifocal papillary thyroid carcinomaHashimoto's thyroiditis
《中国耳鼻咽喉头颈外科》 2026 (5)
247-252,6
评论